Skip to main content
BIO KEY INTERNATIONAL INC logo

BIO KEY INTERNATIONAL INC — Investor Relations & Filings

Ticker · BKYI ISIN · US09060C3097 LEI · 549300VFT6WAQB4BVB07 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,005 across all filing types
Latest filing 2025-05-15 Major Shareholding Noti…
Country US United States of America
Listing US BKYI

About BIO KEY INTERNATIONAL INC

https://www.bio-key.com/

BIO KEY INTERNATIONAL INC is a provider of Identity and Access Management (IAM) and biometric identity solutions. The company develops technologies aimed at creating a secure, passwordless, and phishing-resistant environment for users. Its core offering is the PortalGuard platform, an IAM and Identity-as-a-Service (IDaaS) solution that provides multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset capabilities. A key differentiator is its proprietary Identity-Bound Biometrics, particularly fingerprint identification technology, which is designed for rapid and accurate user verification. BIO-key offers flexible deployment options, including SaaS, hybrid, and on-premises, to support various organizational security strategies such as cloud migration and securing remote workforces.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-15 English
FORM 4
Director's Dealing
2025-05-12 English
FORM 4
Director's Dealing
2025-05-12 English
FORM 4
Director's Dealing
2025-05-12 English
FORM 424B3
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 prospectus filed pursuant to Rule 424(b)(3) related to the resale of shares by a selling stockholder. It details the offering of common stock shares, including information about the selling stockholder, the plan of distribution, risk factors, and other offering details. This type of filing is a capital markets document related to securities offerings and resale of shares, not a financial report, earnings release, or management discussion. It is specifically a prospectus supplement or resale prospectus related to capital raising or share resale activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to the clear identification of the form type and content.
2025-05-12 English
Regulatory Filings 2025
Regulatory Filings
2025-05-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.